Humedix Co., Ltd. (KOSDAQ:200670)

Market Cap	401.45B -0.3%
Revenue (ttm)	110.99B +12.7%
Net Income	9.06B -39.9%
EPS	963.99 -39.3%
Shares Out	10.32M
PE Ratio	40.35
Forward PE	8.74
Dividend	660.00 (1.70%)
Ex-Dividend Date	Nov 24, 2025

Volume	135,468
Average Volume	97,188
Open	40,000
Previous Close	40,750
Day's Range	38,350 - 40,100
52-Week Range	33,050 - 77,200
Beta	0.44
RSI	38.99
Earnings Date	Feb 11, 2026

About Humedix

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 248
• Stock Exchange: KOSDAQ
• Ticker Symbol: 200670

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.